Torigen

Torigen Pharmaceuticals Inc. Focuses on Providing Affordable Immunooncology Products for Companion Animals. Its initial patented product line uses a portion of the pet patient's tumor to create personalized cancer vaccines. With over 10 years of preclinical publication support, the Torigen team is dedicated to developing innovative veterinary cancer biologics that enable the body to recognize foreign tumor-associated antigens and promote the reversal of immune senescence.